ZDHHC8

Chr 22

zDHHC palmitoyltransferase 8

Also known as: DHHC8, ZDHHCL1, ZNF378

The protein functions as a palmitoyltransferase that adds palmitate to various protein substrates, including ABCA1 (regulating cholesterol transport) and potentially the D2 dopamine receptor, thereby controlling their plasma membrane localization and function. Mutations in this gene may be associated with susceptibility to schizophrenia, though definitive pediatric neurological phenotypes are not well-established. The gene is highly constrained against loss-of-function variants (pLI 0.85, LOEUF 0.37), suggesting that complete loss of function is likely deleterious.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.37
Clinical SummaryZDHHC8
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.85) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
314 unique Pathogenic / Likely Pathogenic· 160 VUS of 499 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.37LOEUF
pLI 0.853
Z-score 4.06
OE 0.18 (0.090.37)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.85Z-score
OE missense 0.77 (0.710.84)
403 obs / 522.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.18 (0.090.37)
00.351.4
Missense OE0.77 (0.710.84)
00.61.4
Synonymous OE1.13
01.21.6
LoF obs/exp: 5 / 28.3Missense obs/exp: 403 / 522.1Syn Z: -1.53
DN
0.5576th %ile
GOF
0.6542th %ile
LOF
0.68top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · LOEUF 0.37
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

499 submitted variants in ClinVar

Classification Summary

Pathogenic305
Likely Pathogenic9
VUS160
Likely Benign8
Benign3
305
Pathogenic
9
Likely Pathogenic
160
VUS
8
Likely Benign
3
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
305
0
305
Likely Pathogenic
0
0
9
0
9
VUS
0
151
9
0
160
Likely Benign
0
6
0
2
8
Benign
0
0
3
0
3
Total01573262485

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ZDHHC8 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →